First-line Therapy Selection in HER2+ mBC: Clinical/Nonclinical Factors and New Data

Content Format:

Slideset

Credit Type:

--

Credits:

--
Integrating the Evidence on Adjuvant Therapy for High-risk HR-Positive/HER2-Negative Early Breast Cancer

Content Format:

Slideset

Credit Type:

AAPA | ABIM MOC | ACPE | AMA | ANCC

Credits:

0.50
Integrating the Evidence on Adjuvant Therapy for High-risk HR-Positive/HER2-Negative Early Breast Cancer

Content Format:

Text Module

Credit Type:

AAPA | ABIM MOC | ACPE | AMA | ANCC

Credits:

0.50
Next-Generation Therapeutics for HR+/HER2- Breast Cancer: Spotlight on SERDs

Content Format:

Podcast Episodes

Credit Type:

ABIM MOC | AMA

Credits:

0.75
Next-Generation Therapeutics for HR+/HER2- Breast Cancer: Spotlight on SERDs

Content Format:

Video

Credit Type:

ABIM MOC | AMA

Credits:

1.50
Steps Toward Precision Oncology: Role of SERD in Attacking Endocrine Resistance in HR+/HER2- Breast Cancer

Content Format:

Slideset

Credit Type:

ABIM MOC | AMA

Credits:

0.75
Targeting TROP-2 in Breast Cancer: How Experts Are Integrating TROP-2 ADCs Into Clinical Practice

Content Format:

Slideset

Credit Type:

--

Credits:

--
FAQs: The Expanding Role of Antibody–Drug Conjugates in Breast Cancer

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Optimizing Integration of Precision Therapy Into the Treatment of HER2-Low, HR-Positive, and Triple Negative Breast Cancer: A Focus on HER2 Targeted and TROP-2–Targeted Therapy

Content Format:

Video

Credit Type:

AMA

Credits:

1.50
Incorporating TROP-2–Targeted Therapies Into the Breast Cancer Landscape

Content Format:

Slideset

Credit Type:

--

Credits:

--
Therapeutic Strategies for HER2-Positive Breast Cancer: Exploring Clinical Trial Data and a Treatment Sequence Algorithm

Content Format:

Video

Credit Type:

ABIM MOC | AMA

Credits:

1.00
Therapeutic Strategies for HER2-Positive Breast Cancer Today: Frequently Asked Questions

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
ExpressPointsTherapeutic Strategies for HER2-Positive Breast Cancer: Exploring Clinical Trial Data and a Treatment Sequence Algorithm

Content Format:

Slideset

Credit Type:

--

Credits:

--
Overview of HER2 and Treatment of HER2-Positive Early Breast Cancer

Content Format:

Slideset

Credit Type:

--

Credits:

--
Treatment Selection in HER2-Positive Metastatic Breast Cancer

Content Format:

Slideset

Credit Type:

--

Credits:

--
Interactive Decision Support Tool: HER2-Positive Metastatic Breast Cancer Expert Guidance

Content Format:

Tool

Credit Type:

--

Credits:

--
Update on ADCs and Biomarkers in Breast, Gastrointestinal, and Lung Cancers

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
HER2, HER3, and TROP2: An Update on Novel Treatments for Key Targets

Content Format:

Multimedia

Credit Type:

AMA

Credits:

2.00
How We Are Integrating New Findings Into Treatment for HER2-Positive Breast Cancer

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Smarter. Stronger. Together: Achieving Quality HER2-Positive Breast Cancer Care by Educating Providers and Patients

Content Format:

Multimedia

Credit Type:

ACPE | AMA | ANCC

Credits:

1.50
Mastering the Evolving Treatment Landscape in HER2-Positive Breast Cancer: Current Guidance and Future Perspectives

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
Targeting HER2, TROP2 and HER3: Spotlight on Breast Cancer

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
Express PointsSmarter. Stronger. Together: Achieving Quality HER2-Positive Breast Cancer Care by Educating Providers and Patients

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
Mastering the Evolving Treatment Landscape in HER2-Positive Breast Cancer: Current Guidance and Future Perspectives

Content Format:

Multimedia

Credit Type:

ACPE | AMA | ANCC

Credits:

1.00